Fig. 4From: Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancerPlasma Endoxifen concentrations in women with estrogen receptor-positive breast cancer in relation to major groups of CYP3A5 phenotypeBack to article page